These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

430 related articles for article (PubMed ID: 30622188)

  • 21. Development of a vesicular stomatitis virus pseudotyped with herpes B virus glycoproteins and its application in a neutralizing antibody detection assay.
    Kinoshita H; Yamada S; Ogawa T; Nguyen PHA; Harada S; Kawahara M; Ishijima K; Maeda K; Ebihara H; Fukushi S
    mBio; 2024 Jul; 15(7):e0109224. PubMed ID: 38847539
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spontaneous Mutation at Amino Acid 544 of the Ebola Virus Glycoprotein Potentiates Virus Entry and Selection in Tissue Culture.
    Ruedas JB; Ladner JT; Ettinger CR; Gummuluru S; Palacios G; Connor JH
    J Virol; 2017 Aug; 91(15):. PubMed ID: 28539437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of a lentiviral vector system to study the role of the Andes virus glycoproteins.
    Cifuentes-Muñoz N; Darlix JL; Tischler ND
    Virus Res; 2010 Oct; 153(1):29-35. PubMed ID: 20619306
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Defining of MAbs-neutralizing sites on the surface glycoproteins Gn and Gc of a hantavirus using vesicular stomatitis virus pseudotypes and site-directed mutagenesis.
    Levanov L; Iheozor-Ejiofor RP; Lundkvist Å; Vapalahti O; Plyusnin A
    J Gen Virol; 2019 Feb; 100(2):145-155. PubMed ID: 30624178
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Truncated hantavirus nucleocapsid proteins for serotyping Hantaan, Seoul, and Dobrava hantavirus infections.
    Araki K; Yoshimatsu K; Ogino M; Ebihara H; Lundkvist A ; Kariwa H; Takashima I; Arikawa J
    J Clin Microbiol; 2001 Jul; 39(7):2397-404. PubMed ID: 11427545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human antibody recognizing a quaternary epitope in the Puumala virus glycoprotein provides broad protection against orthohantaviruses.
    Mittler E; Wec AZ; Tynell J; Guardado-Calvo P; Wigren-Byström J; Polanco LC; O'Brien CM; Slough MM; Abelson DM; Serris A; Sakharkar M; Pehau-Arnaudet G; Bakken RR; Geoghegan JC; Jangra RK; Keller M; Zeitlin L; Vapalahti O; Ulrich RG; Bornholdt ZA; Ahlm C; Rey FA; Dye JM; Bradfute SB; Strandin T; Herbert AS; Forsell MNE; Walker LM; Chandran K
    Sci Transl Med; 2022 Mar; 14(636):eabl5399. PubMed ID: 35294259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T-cell immunoglobulin and mucin (TIM) contributes to the infection of human airway epithelial cells by pseudotype viruses containing Hantaan virus glycoproteins.
    Mayor J; Torriani G; Rothenberger S; Engler O
    Virology; 2020 Apr; 543():54-62. PubMed ID: 32056847
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Single dose recombinant VSV based vaccine elicits robust and durable neutralizing antibody against Hantaan virus.
    Zhang H; Liu H; Wei J; Dang Y; Wang Y; Yang Q; Zhang L; Ye C; Wang B; Jin X; Cheng L; Ma H; Dong Y; Li Y; Bai Y; Lv X; Lei Y; Xu Z; Ye W; Zhang F
    NPJ Vaccines; 2024 Feb; 9(1):28. PubMed ID: 38341504
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A pseudotype vesicular stomatitis virus containing Hantaan virus envelope glycoproteins G1 and G2 as an alternative to hantavirus vaccine in mice.
    Lee BH; Yoshimatsu K; Araki K; Okumura M; Nakamura I; Arikawa J
    Vaccine; 2006 Apr; 24(15):2928-34. PubMed ID: 16426712
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical characterization of Dobrava hantavirus infections in Germany.
    Schütt M; Gerke P; Meisel H; Ulrich R; Krüger DH
    Clin Nephrol; 2001 May; 55(5):371-4. PubMed ID: 11393382
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Study of Andes virus entry and neutralization using a pseudovirion system.
    Ray N; Whidby J; Stewart S; Hooper JW; Bertolotti-Ciarlet A
    J Virol Methods; 2010 Feb; 163(2):416-23. PubMed ID: 19903496
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular characterization of Dobrava-Belgrade hantavirus in Serbia, 2007-2011.
    Stanojevic M; Cirkovic V; Siljic M; Gligic A; Stamenkovic G
    J Infect Public Health; 2019; 12(5):645-649. PubMed ID: 30910417
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical characterization of two severe cases of hemorrhagic fever with renal syndrome (HFRS) caused by hantaviruses Puumala and Dobrava-Belgrade genotype Sochi.
    Krautkrämer E; Nusshag C; Baumann A; Schäfer J; Hofmann J; Schnitzler P; Klempa B; Witkowski PT; Krüger DH; Zeier M
    BMC Infect Dis; 2016 Nov; 16(1):675. PubMed ID: 27842513
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of nucleocapsid protein of hantaviruses in intracellular traffic of viral glycoproteins.
    Shimizu K; Yoshimatsu K; Koma T; Yasuda SP; Arikawa J
    Virus Res; 2013 Dec; 178(2):349-56. PubMed ID: 24070985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of the Hantavirus Fusion Process by Predicted Domain III and Stem Peptides from Glycoprotein Gc.
    Barriga GP; Villalón-Letelier F; Márquez CL; Bignon EA; Acuña R; Ross BH; Monasterio O; Mardones GA; Vidal SE; Tischler ND
    PLoS Negl Trop Dis; 2016 Jul; 10(7):e0004799. PubMed ID: 27414047
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Single-Vector, Single-Injection Recombinant Vesicular Stomatitis Virus Vaccines Against High-Containment Viruses.
    Whitt MA; Geisbert TW; Mire CE
    Methods Mol Biol; 2016; 1403():295-311. PubMed ID: 27076138
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Production and Purification of Hantavirus Glycoproteins in Drosophila melanogaster S2 Cells.
    Meola A; Guardado-Calvo P
    Methods Mol Biol; 2024; 2762():3-16. PubMed ID: 38315356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Co-circulation of three pathogenic hantaviruses: Puumala, Dobrava, and Saaremaa in Hungary.
    Plyusnina A; Ferenczi E; Rácz GR; Nemirov K; Lundkvist A; Vaheri A; Vapalahti O; Plyusnin A
    J Med Virol; 2009 Dec; 81(12):2045-52. PubMed ID: 19856478
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Properties of replication-competent vesicular stomatitis virus vectors expressing glycoproteins of filoviruses and arenaviruses.
    Garbutt M; Liebscher R; Wahl-Jensen V; Jones S; Möller P; Wagner R; Volchkov V; Klenk HD; Feldmann H; Ströher U
    J Virol; 2004 May; 78(10):5458-65. PubMed ID: 15113924
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Surrogate Animal Model for Screening of Ebola and Marburg Glycoprotein-Targeting Drugs Using Pseudotyped Vesicular Stomatitis Viruses.
    Saito T; Maruyama J; Nagata N; Isono M; Okuya K; Takadate Y; Kida Y; Miyamoto H; Mori-Kajihara A; Hattori T; Furuyama W; Ogawa S; Iida S; Takada A
    Viruses; 2020 Aug; 12(9):. PubMed ID: 32842671
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.